Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 1,656

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA)

·2014·European Heart Journal

Abstract

Linee guida

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehu282

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Research works printed but not linked: 264

  1. Weiser, 2008, An estimation of the global volume of surgery: a modelling strategy based on available data, Lancet, 372, 139, 10.1016/S0140-6736(08)60878-8 · DOI · Paper page
  2. Devereaux, 2012, Association between post-operative troponin levels and 30-day mortality among patients undergoing noncardiac surgery, JAMA, 307, 2295, 10.1001/jama.2012.5502 · DOI · Paper page
  3. Naughton, 2007, The impact of age on 6-month survival in patients with cardiovascular risk factors undergoing elective non-cardiac surgery, Int J Clin Pract, 61, 768, 10.1111/j.1742-1241.2007.01304.x · DOI
  4. Mangano, 2004, Peri-operative medicine, J Cardiothorac Vasc Anesth, 18, 1, 10.1053/j.jvca.2003.10.002 · DOI
  5. Ferguson, 2002, A decade of change: Risk profiles and outcomes for isolated coronary artery bypass grafting procedures, 1990–1999: A report from the STS National Database Committee and the Duke Clinical Research Institute, Ann Thorac Surg, 73, 480, 10.1016/S0003-4975(01)03339-2 · DOI · Paper page
  6. Carroll, 2003, Prevalence and management of coronary heart disease in primary care: population-based cross-sectional study using a disease register, J Public Health Med, 25, 29, 10.1093/pubmed/fdg007 · DOI
  7. Fletcher, 2013, Patients with aortic stenosis: who should undergo noncardiac surgery in a rural hospital?, J Perianesth Nurs, 28, 368, 10.1016/j.jopan.2012.10.010 · doi:10.1016/j.jopan.2012.10.010
  8. Wirthlin, 1998, Surgery-specific considerations in the cardiac patient undergoing noncardiac surgery, Prog Cardiovasc Dis, 40, 453, 10.1016/S0033-0620(98)80017-0 · DOI
  9. Guay, 2014, Neuraxial blockade for the prevention of post-operative mortality and major morbidity: an overview of Cochrane systematic reviews, Cochrane Database Syst Rev, 1
  10. Glance, 2012, The Surgical Mortality Probability Model: derivation and validation of a simple risk prediction rule for noncardiac surgery, Ann Surg, 255, 696, 10.1097/SLA.0b013e31824b45af · DOI · Paper page
  11. Wang, 2014, The short- and long-term outcomes of laparoscopic vs. open surgery for colorectal cancer: a meta-analysis, Int J Colorectal Dis, 10.1007/s00384-013-1827-1 · doi:10.1007/s00384-013-1827-1
  12. Rosenmüller, 2013, Expertise-based randomized clinical trial of laparoscopic vs. small-incision open cholecystectomy, Br J Surg, 100, 886, 10.1002/bjs.9133 · DOI
  13. Bauer, 2010, New developments in the pre-operative evaluation and peri-operative management of coronary artery disease in patients undergoing vascular surgery, J Vasc Surg, 51, 242, 10.1016/j.jvs.2009.08.087 · DOI
  14. Brown, 2012, The UK EndoVascular Aneurysm Repair (EVAR) trials: randomised trials of EVAR vs. standard therapy, Health Technol Assess, 16, 1, 10.3310/hta16090 · DOI · Paper page
  15. Stather, 2013, Systematic review and meta-analysis of the early and late outcomes of open and endovascular repair of abdominal aortic aneurysm, Br J Surg, 100, 863, 10.1002/bjs.9101 · DOI · Paper page
  16. Paravastu, 2014, Endovascular repair of abdominal aortic aneurysm, Cochrane Database Syst Rev, 1
  17. Antoniou, 2013, A meta-analysis of endovascular vs. surgical reconstruction of femoropopliteal arterial disease, J Vasc Surg, 57, 242, 10.1016/j.jvs.2012.07.038 · DOI
  18. Cutlip, 2012, Extracranial carotid disease revascularization, Circulation, 126, 2636, 10.1161/CIRCULATIONAHA.112.110411 · DOI
  19. Naylor, 2012, Time to rethink management strategies in asymptomatic carotid artery disease, Nat Rev Cardiol, 9, 116, 10.1038/nrcardio.2011.151 · DOI · Paper page
  20. Nallamothu, 2011, Operator experience and carotid stenting outcomes in Medicare beneficiaries, JAMA, 306, 1338, 10.1001/jama.2011.1357 · DOI · Paper page
  21. Holte, 2000, Post-operative ileus: a preventable event, Br J Surg, 87, 1480, 10.1046/j.1365-2168.2000.01595.x · DOI · Paper page
  22. Popescu, 2011, A pilot study of patients with clinically severe obesity undergoing laparoscopic surgery: evidence for impaired cardiac performance, J Cardiothorac Vasc Anesth, 25, 943, 10.1053/j.jvca.2010.11.012 · DOI
  23. Lestar, 2011, Hemodynamic perturbations during robot-assisted laparoscopic radical prostatectomy in 45° Trendelenburg position, Anesth Analg, 113, 1069, 10.1213/ANE.0b013e3182075d1f · doi:10.1213/ane.0b013e3182075d1f
  24. Hirvonen, 1995, Hemodynamic changes due to Trendelenburg positioning and pneumoperitoneum during laparoscopic hysterectomy, Acta Anaesthesiol Scand, 39, 949, 10.1111/j.1399-6576.1995.tb04203.x · doi:10.1111/j.1399-6576.1995.tb04203.x
  25. Nguyen, 2005, The physiologic effects of pneumoperitoneum in the morbidly obese, Annals of Surgery, 241, 219, 10.1097/01.sla.0000151791.93571.70 · DOI · Paper page
  26. Keus, 2010, Open, small-incision, or laparoscopic cholecystectomy for patients with symptomatic cholecystolithiasis. An overview of Cochrane Hepato-Biliary Group reviews, Cochrane Database Syst Rev, 10.1002/14651858.CD008318 · DOI · Paper page
  27. Mamidanna, 2012, Reduced risk of medical morbidity and mortality in patients selected for laparoscopic colorectal resection in England: a population-based study, Arch Surg, 147, 219, 10.1001/archsurg.2011.311 · DOI
  28. Cirocchi, 2012, Elective sigmoid colectomy for diverticular disease. Laparoscopic vs. open surgery: a systematic review, Colorectal Dis, 14, 671, 10.1111/j.1463-1318.2011.02666.x · doi:10.1111/j.1463-1318.2011.02666.x
  29. Murr, 2007, A state-wide review of contemporary outcomes of gastric bypass in Florida: does provider volume impact outcomes?, Ann Surg, 245, 699, 10.1097/01.sla.0000256392.04141.04 · DOI
  30. Grailey, 2013, Laparoscopic vs. open colorectal resection in the elderly population, Surg Endosc, 27, 19, 10.1007/s00464-012-2414-1 · DOI
  31. Cao, 2013, Video-assisted thoracic surgery vs. open thoracotomy for non-small cell lung cancer: a meta-analysis of propensity score-matched patients, Interact Cardiovasc Thorac Surg, 16, 244, 10.1093/icvts/ivs472 · doi:10.1093/icvts/ivs472
  32. De Martino, 2013, Designation as "unfit for open repair" is associated with poor outcomes after endovascular aortic aneurysm repair, Circ Cardiovasc Qual Outcomes, 6, 575, 10.1161/CIRCOUTCOMES.113.000303 · doi:10.1161/circoutcomes.113.000303
  33. Hlatky, 1989, A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index), Am J Cardiol, 64, 651, 10.1016/0002-9149(89)90496-7 · DOI · Paper page
  34. Biccard, 2005, Relationship between the inability to climb two flights of stairs and outcome after major non-cardiac surgery: implications for the pre-operative assessment of functional capacity, Anaesthesia, 60, 588, 10.1111/j.1365-2044.2005.04181.x · DOI
  35. Wiklund, 2001, Activities of daily living and cardiovascular complications following elective, noncardiac surgery, Yale J Biol Med, 74, 75
  36. Morris, 1991, The prognostic value of exercise capacity: a review of the literature, Am Heart J, 122, 1423, 10.1016/0002-8703(91)90586-7 · DOI · Paper page
  37. Goldman, 1977, Multifactorial index of cardiac risk in noncardiac surgical procedures, N Engl J Med, 297, 845, 10.1056/NEJM197710202971601 · DOI · Paper page
  38. Detsky, 1986, Cardiac assessment for patients undergoing noncardiac surgery. A multifactorial clinical risk index, Arch Intern Med, 146, 2131, 10.1001/archinte.1986.00360230047007 · doi:10.1001/archinte.1986.00360230047007 · Paper page
  39. Lee, 1999, Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery, Circulation, 100, 1043, 10.1161/01.CIR.100.10.1043 · DOI · Paper page
  40. Gupta, 2011, Development and validation of a risk calculator for prediction of cardiac risk after surgery, Circulation, 124, 381, 10.1161/CIRCULATIONAHA.110.015701 · DOI · Paper page
  41. Ford, 2010, Systematic review: prediction of peri-operative cardiac complications and mortality by the revised cardiac risk index, Ann Intern Med, 152, 26, 10.7326/0003-4819-152-1-201001050-00007 · DOI · Paper page
  42. Maisel, 2006, Cardiac biomarkers: a contemporary status report, Nat Clin Pract Cardiovasc Med, 3, 24, 10.1038/ncpcardio0405 · DOI
  43. Priebe, 2005, Peri-operative myocardial infarction: aetiology and prevention, Br J Anaesth, 95, 3, 10.1093/bja/aei063 · DOI · Paper page
  44. Weber, 2013, Incremental value of high-sensitive troponin T in addition to the revised cardiac index for peri-operative risk stratification in non-cardiac surgery, Eur Heart J, 34, 853, 10.1093/eurheartj/ehs445 · doi:10.1093/eurheartj/ehs445
  45. Thygesen, 2012, Third universal definition of myocardial infarction, Eur Heart J, 33, 2551, 10.1093/eurheartj/ehs184 · DOI · Paper page
  46. Wang, 2004, Plasma natriuretic peptide levels and the risk of cardiovascular events and death, N Engl J Med, 350, 655, 10.1056/NEJMoa031994 · DOI · Paper page
  47. Dernellis, 2006, Assessment of cardiac risk before non-cardiac surgery: brain natriuretic peptide in 1590 patients, Heart, 92, 1645, 10.1136/hrt.2005.085530 · DOI
  48. Rodseth, 2008, A meta-analysis of the utility of pre-operative brain natriuretic peptide in predicting early and intermediate-term mortality and major adverse cardiac events in vascular surgical patients, Anaesthesia, 63, 1226, 10.1111/j.1365-2044.2008.05574.x · DOI
  49. Karthikeyan, 2009, Is a pre-operative brain natriuretic peptide or N-terminal pro-B-type natriuretic peptide measurement an independent predictor of adverse cardiovascular outcomes within 30 days of noncardiac surgery? A systematic review and meta-analysis of observational studies, J Am Coll Cardiol, 54, 1599, 10.1016/j.jacc.2009.06.028 · DOI · Paper page
  50. Moonesinghe, 2013, Risk stratification tools for predicting morbidity and mortality in adult patients undergoing major surgery: qualitative systematic review, Anesthesiology, 119, 959, 10.1097/ALN.0b013e3182a4e94d · DOI · Paper page
  51. Rodseth, 2014, The prognostic value of pre-operative and post-operative B-type natriuretic peptides in patients undergoing noncardiac surgery: B-type natriuretic Peptide and N-terminal fragment of pro-B-type natriuretic Peptide: a systematic review and individual patient data meta-analysis, J Am Coll Cardiol, 63, 170, 10.1016/j.jacc.2013.08.1630 · DOI · Paper page
  52. Montalescot, 2013, 2013 ESC guidelines on the management of stable coronary artery disease: The Task Force on the management of stable coronary artery disease of the European Society of Cardiology, Eur Heart J, 34, 2949, 10.1093/eurheartj/eht296 · DOI · Paper page
  53. Jeger, 2006, Long-term prognostic value of the pre-operative 12-lead electrocardiogram before major noncardiac surgery in coronary artery disease, Am Heart J, 151, 508, 10.1016/j.ahj.2005.04.018 · DOI
  54. Halm, 1996, Echocardiography for assessing cardiac risk in patients having noncardiac surgery. Study of Peri-operative Ischemia Research Group, Ann Intern Med, 125, 433, 10.7326/0003-4819-125-6-199609150-00001 · doi:10.7326/0003-4819-125-6-199609150-00001
  55. Rohde, 2001, Usefulness of transthoracic echocardiography as a tool for risk stratification of patients undergoing major noncardiac surgery, Am J Cardiol, 87, 505, 10.1016/S0002-9149(00)01421-1 · DOI · Paper page
  56. Etchells, 2002, Semi-quantitative dipyridamole myocardial stress perfusion imaging for cardiac risk assessment before noncardiac vascular surgery: A metaanalysis, J Vasc Surg, 36, 534, 10.1067/mva.2002.126563 · doi:10.1067/mva.2002.126563
  57. Shaw, 1996, Meta-analysis of intravenous dipyridamole-thallium-201 imaging (1985 to 1994) and dobutamine echocardiography (1991 to 1994) for risk stratification before vascular surgery, J Am Coll Cardiol, 27, 787, 10.1016/0735-1097(95)00549-8 · DOI
  58. Sicari, 2009, Stress Echocardiography Expert Consensus Statement: Executive Summary: European Association of Echocardiography (EAE) (a registered branch of the ESC), Eur Heart J, 30, 278, 10.1093/eurheartj/ehn492 · DOI · Paper page
  59. Das, 2000, Assessment of cardiac risk before nonvascular surgery: dobutamine stress echocardiography in 530 patients, J Am Coll Cardiol, 35, 1647, 10.1016/S0735-1097(00)00586-6 · doi:10.1016/s0735-1097(00)00586-6
  60. Raux, 2006, Low negative predictive value of dobutamine stress echocardiography before abdominal aortic surgery, Br J Anaesth, 97, 770, 10.1093/bja/ael246 · doi:10.1093/bja/ael246
  61. Labib, 2004, Cardiac events in patients with negative maximal vs. negative submaximal dobutamine echocardiograms undergoing noncardiac surgery: importance of resting wall motion abnormalities, J Am Coll Cardiol, 44, 82, 10.1016/j.jacc.2004.03.049 · DOI
  62. Nandalur, 2007, Diagnostic performance of stress cardiac magnetic resonance imaging in the detection of coronary artery disease: A meta-analysis, J Am Coll Cardiol, 50, 1343, 10.1016/j.jacc.2007.06.030 · DOI · Paper page
  63. Schwitter, 2013, MR-IMPACT II: Magnetic Resonance Imaging for Myocardial Perfusion Assessment in Coronary artery disease Trial: perfusion-cardiac magnetic resonance vs. single-photon emission computed tomography for the detection of coronary artery disease: a comparative multicentre, multivendor trial, Eur Heart J, 34, 775, 10.1093/eurheartj/ehs022 · DOI · Paper page
  64. Rerkpattanapipat, 2002, Assessment of pre-operative cardiac risk with magnetic resonance imaging, Am J Cardiol, 90, 416, 10.1016/S0002-9149(02)02501-8 · DOI
  65. Vahanian, 2012, Guidelines on the management of valvular heart disease (version 2012): The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), Eur Heart J, 33, 2451, 10.1093/eurheartj/ehs109 · DOI · Paper page
  66. Knuuti, 2013, Risks and benefits of cardiac imaging: an analysis of risks related to imaging for coronary artery disease, Eur Heart J, 35, 633, 10.1093/eurheartj/eht512 · DOI
  67. Patel, 2012, ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS 2012 appropriate use criteria for diagnostic catheterization: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society of Critical Care Medicine, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons, J Am Coll Cardiol, 59, 1995, 10.1016/j.jacc.2012.03.003 · DOI · Paper page
  68. Hamm, 2011, ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC), Eur Heart J, 32, 2999, 10.1093/eurheartj/ehr236 · DOI · Paper page
  69. Wijns, 2010, Guidelines on myocardial revascularization, Eur Heart J, 31, 2501, 10.1093/eurheartj/ehq277 · DOI · Paper page
  70. Steg, 2012, ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation, Eur Heart J, 33, 2569, 10.1093/eurheartj/ehs215 · DOI · Paper page
  71. Illuminati, 2010, Systematic pre-operative coronary angiography and stenting improves post-operative results of carotid endarterectomy in patients with asymptomatic coronary artery disease: a randomised controlled trial, Eur J Vasc Endovasc Surg, 39, 139, 10.1016/j.ejvs.2009.11.015 · DOI
  72. Lüscher, 2014, Is the panic about beta-blockers in peri-operative care justified?, Eur Heart J, 10.1093/eurheartj/ehu056 · doi:10.1093/eurheartj/ehu056
  73. Devereaux, 2008, Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial, Lancet, 371, 1839, 10.1016/S0140-6736(08)60601-7 · DOI · Paper page
  74. Zaugg, 2007, Adrenergic receptor genotype but not peri-operative bisoprolol therapy may determine cardiovascular outcome in at-risk patients undergoing surgery with spinal block: The Swiss Beta Blocker in Spinal Anesthesia (BBSA) study: A double-blinded, placebo-controlled, multicenter trial with 1-year follow-up, Anesthesiology, 107, 33, 10.1097/01.anes.0000267530.62344.a4 · doi:10.1097/01.anes.0000267530.62344.a4
  75. Yang, 2006, The effects of peri-operative beta-blockade: Results of the Metoprolol after Vascular Surgery (MaVS) study, a randomized controlled trial, Am Heart J, 152, 983, 10.1016/j.ahj.2006.07.024 · DOI · Paper page
  76. Juul, 2006, Effect of peri-operative beta blockade in patients with diabetes undergoing major non-cardiac surgery: randomised placebo controlled, blinded multicentre trial, BMJ, 332, 1482, 10.1136/bmj.332.7556.1482 · DOI · Paper page
  77. Brady, 2005, Peri-operative beta-blockade (POBBLE) for patients undergoing infrarenal vascular surgery: results of a randomized double-blind controlled trial, J Vasc Surg, 41, 602, 10.1016/j.jvs.2005.01.048 · DOI · Paper page
  78. Mangano, 1996, Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Peri-operative Ischemia Research Group, New Engl J Med, 335, 1713, 10.1056/NEJM199612053352301 · DOI · Paper page
  79. Alonso-Coello, 2008, Should physicians initiate beta-blocker therapy in patients undergoing non-cardiac surgery? Insights from the POISE trial, Pol Arch Med Wewn, 118, 616, 10.20452/pamw.502 · doi:10.20452/pamw.502
  80. Bouri, 2014, Meta-analysis of secure randomised controlled trials of beta-blockade to prevent peri-operative death in non-cardiac surgery, Heart, 100, 456, 10.1136/heartjnl-2013-304262 · DOI · Paper page
  81. Angeli, 2010, β-Blockers reduce mortality in patients undergoing high-risk non-cardiac surgery, Am J Cardiovasc Drugs, 10, 247, 10.2165/11539510-000000000-00000 · DOI
  82. Devereaux, 2005, How strong is the evidence for the use of peri-operative beta blockers in non-cardiac surgery? Systematic review and meta-analysis of randomised controlled trials, BMJ (Clinical research ed), 331, 313, 10.1136/bmj.38503.623646.8F · DOI · Paper page
  83. McGory, 2005, A meta-analysis of peri-operative beta blockade: what is the actual risk reduction?, Surgery, 138, 171, 10.1016/j.surg.2005.03.022 · DOI
  84. Stevens, 2003, Pharmacologic myocardial protection in patients undergoing noncardiac surgery: a quantitative systematic review, Anesth analg, 97, 623, 10.1213/01.ANE.0000074795.68061.16 · DOI · Paper page
  85. Wiesbauer, 2007, Peri-operative beta-blockers for preventing surgery-related mortality and morbidity: a systematic review and meta-analysis, Anesth analg, 104, 27, 10.1213/01.ane.0000247805.00342.21 · DOI
  86. Auerbach, 2002, β-Blockers and reduction of cardiac events in noncardiac surgery: scientific review, JAMA, 287, 1435
  87. Bangalore, 2008, Peri-operative beta blockers in patients having non-cardiac surgery: a meta-analysis, Lancet, 372, 1962, 10.1016/S0140-6736(08)61560-3 · DOI · Paper page
  88. Leibowitz, 2010, Can meta-analysis of the current literature help determine if peri-operative beta-blockers improve outcome of high-risk patients undergoing noncardiac surgery?, J Cardiothorac Vasc Anesth, 24, 217, 10.1053/j.jvca.2010.01.014 · doi:10.1053/j.jvca.2010.01.014
  89. Beattie, 2008, Does tight heart rate control improve beta-blocker efficacy? An updated analysis of the noncardiac surgical randomized trials, Anesth Analg, 106, 1039, 10.1213/ane.0b013e318163f6a9 · doi:10.1213/ane.0b013e318163f6a9
  90. Lindenauer, 2005, Peri-operative beta-blocker therapy and mortality after major noncardiac surgery, N Engl J Med, 353, 349, 10.1056/NEJMoa041895 · DOI · Paper page
  91. Shammash, 2001, Peri-operative beta-blocker withdrawal and mortality in vascular surgical patients, Am Heart J, 141, 148, 10.1067/mhj.2001.111547 · DOI · Paper page
  92. London, 2013, Association of peri-operative beta-blockade with mortality and cardiovascular morbidity following major noncardiac surgery, JAMA, 309, 1704, 10.1001/jama.2013.4135 · DOI · Paper page
  93. Wallace, 2010, Association of the pattern of use of peri-operative beta-blockade and post-operative mortality, Anesthesiology, 113, 794, 10.1097/ALN.0b013e3181f1c061 · DOI
  94. Kwon, 2012, β-blocker continuation after noncardiac surgery: a report from the surgical care and outcomes assessment program, Arch Surg, 147, 467, 10.1001/archsurg.2011.1698 · DOI
  95. Wallace, 2011, Peri-operative beta-blockade: atenolol is associated with reduced mortality when compared with metoprolol, Anesthesiology, 114, 824, 10.1097/ALN.0b013e3182110e83 · DOI
  96. Redelmeier, 2005, β-blockers for elective surgery in elderly patients: population based, retrospective cohort study, BMJ (Clinical research ed), 331, 932, 10.1136/bmj.38603.746944.3A · DOI
  97. Ashes, 2013, Selective β1-Antagonism with Bisoprolol Is Associated with Fewer Post-operative Strokes than Atenolol or Metoprolol: A Single-center Cohort Study of 44,092 Consecutive Patients, Anesthesiology, 119, 777, 10.1097/ALN.0b013e3182a17f12 · DOI
  98. Ellenberger, 2011, Chronic beta blockade is associated with a better outcome after elective noncardiac surgery than acute beta blockade: a single-center propensity-matched cohort study, Anesthesiology, 114, 817, 10.1097/ALN.0b013e31820fca0b · DOI
  99. Walsh, 2013, Relationship between intra-operative mean arterial pressure and clinical outcomes after noncardiac surgery: toward an empirical definition of hypotension, Anesthesiology, 119, 507, 10.1097/ALN.0b013e3182a10e26 · DOI · Paper page
  100. Andersson, 2014, Association of β-Blocker Therapy With Risks of Adverse Cardiovascular Events and Deaths in Patients With Ischemic Heart Disease Undergoing Noncardiac Surgery: A Danish Nationwide Cohort Study, JAMA Intern Med, 174, 336, 10.1001/jamainternmed.2013.11349 · DOI
  101. Wallace, 1998, Prophylactic atenolol reduces post-operative myocardial ischemia. McSPI Research Group, Anesthesiology, 88, 7, 10.1097/00000542-199801000-00005 · DOI · Paper page
  102. Lindenauer, 2004, Lipid-lowering therapy and in-hospital mortality following major noncardiac surgery, JAMA, 291, 2092, 10.1001/jama.291.17.2092 · DOI · Paper page
  103. Hindler, 2006, Improved post-operative outcomes associated with pre-operative statin therapy, Anesthesiology, 105, 10.1097/00000542-200612000-00027 · DOI · Paper page
  104. Desai, 2010, Incidence of peri-operative myocardial infarction and of 2-year mortality in 577 elderly patients undergoing noncardiac vascular surgery treated with and without statins, Arch Gerontol Geriatr, 51, 149, 10.1016/j.archger.2009.09.042 · DOI
  105. Lau, 2013, Impact of adding aspirin to Beta-blocker and statin in high-risk patients undergoing major vascular surgery, Ann Vasc Surg, 27, 537, 10.1016/j.avsg.2012.12.001 · DOI
  106. Chopra, 2012, Effect of peri-operative statins on death, myocardial infarction, atrial fibrillation, and length of stay: a systematic review and meta-analysis, Arch Surg, 147, 181, 10.1001/archsurg.2011.897 · DOI
  107. Winchester, 2010, Evidence of pre-procedural statin therapy a meta-analysis of randomized trials, J Am Coll Cardiol, 56, 1099, 10.1016/j.jacc.2010.04.023 · DOI
  108. Le Manach, 2011, Impact of pre-operative statin therapy on adverse post-operative outcomes in patients undergoing vascular surgery, Anesthesiology, 114, 98, 10.1097/ALN.0b013e31820254a6 · DOI
  109. Sanders, 2013, Peri-operative statin therapy for improving outcomes during and after noncardiac vascular surgery, Cochrane database syst rev, 7
  110. McNally, 2010, Pre-operative statin therapy is associated with improved outcomes and resource utilization in patients undergoing aortic aneurysm repair, J Vasc Surg, 51, 1390, 10.1016/j.jvs.2010.01.028 · DOI
  111. Verzini, 2011, Effects of statins on early and late results of carotid stenting, J Vasc Surg, 53
  112. Le Manach, 2007, The impact of post-operative discontinuation or continuation of chronic statin therapy on cardiac outcome after major vascular surgery, Anesth Analg, 104, 1326, 10.1213/01.ane.0000263029.72643.10 · DOI · Paper page
  113. Kertai, 2008, Dihydropiridine calcium-channel blockers and peri-operative mortality in aortic aneurysm surgery, Br J Anaesthesia, 101, 458, 10.1093/bja/aen173 · doi:10.1093/bja/aen173
  114. Devereaux, 2014, Clonidine in patients undergoing noncardiac surgery, N Engl J Med, 370, 1504, 10.1056/NEJMoa1401106 · DOI · Paper page
  115. Burger, 2005, Low-dose aspirin for secondary cardiovascular prevention: cardiovascular risks after its peri-operative withdrawal vs. bleeding risks with its continuation: review and meta-analysis, J Int Med, 257, 399, 10.1111/j.1365-2796.2005.01477.x · DOI · Paper page
  116. Devereaux, 2014, Aspirin in patients undergoing noncardiac surgery, N Engl J Med, 370, 1494, 10.1056/NEJMoa1401105 · DOI · Paper page
  117. Patrono, 2011, Anti-platelet agents for the treatment and prevention of atherothrombosis, Eur Heart J, 32, 2922, 10.1093/eurheartj/ehr373 · DOI · Paper page
  118. Korte, 2011, Peri-operative management of anti-platelet therapy in patients with coronary artery disease: joint position paper by members of the working group on Peri-operative Haemostasis of the Society on Thrombosis and Haemostasis Research (GTH), the working group on Peri-operative Coagulation of the Austrian Society for Anesthesiology, Resuscitation and Intensive Care (ÖGARI) and the Working Group Thrombosis of the European Society for Cardiology (ESC), Thromb Haemost, 105, 743, 10.1160/TH10-04-0217 · DOI · Paper page
  119. Sun, 2008, The effect of pre-operative aspirin on bleeding, transfusion, myocardial infarction, and mortality in coronary artery bypass surgery: a systematic review of randomized and observational studies, Eur Heart J, 29, 1057, 10.1093/eurheartj/ehn104 · DOI
  120. Hawn, 2013, Risk of major adverse cardiac events following noncardiac surgery in patients with coronary stents, JAMA, 310, 1462, 10.1001/jama.2013.278787 · DOI · Paper page
  121. Huber, 1992, Outcome of noncardiac operations in patients with severe coronary-artery disease successfully treated pre-operatively with coronary angioplasty, Mayo Clin Proc, 67, 15, 10.1016/S0025-6196(12)60271-7 · doi:10.1016/s0025-6196(12)60271-7
  122. Kaluza, 2000, Catastrophic outcomes of noncardiac surgery soon after coronary stenting, J Am Coll Cardiol, 35, 1288, 10.1016/S0735-1097(00)00521-0 · DOI · Paper page
  123. Nuttall, 2008, Time and cardiac risk of surgery after bare-metal stent percutaneous coronary intervention, Anesthesiology, 109, 588, 10.1097/ALN.0b013e318186ddf8 · DOI · Paper page
  124. Berger, 2010, Frequency of major noncardiac surgery and subsequent adverse events in the year after drug-eluting stent placement results from the EVENT (Evaluation of Drug-Eluting Stents and Ischemic Events) Registry, JACC Cardiovasc Interv, 3, 920, 10.1016/j.jcin.2010.03.021 · DOI · Paper page
  125. Baber, 2011, Impact of the everolimus-eluting stent on stent thrombosis: a meta-analysis of 13 randomized trials, J Am Coll Cardiol, 58, 1569, 10.1016/j.jacc.2011.06.049 · DOI · Paper page
  126. Feres, 2013, Three vs. twelve months of dual anti-platelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial, JAMA, 310, 2510
  127. Wijns, 2010, Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), Eur Heart J, 31, 2501, 10.1093/eurheartj/ehq277 · DOI · Paper page
  128. Ferraris, 2012, update to the Society of Thoracic Surgeons guideline on use of anti-platelet drugs in patients having cardiac and noncardiac operations, Ann Thorac Surg 2012, 94, 1761, 10.1016/j.athoracsur.2012.07.086 · DOI · Paper page
  129. Mahla, 2012, Platelet function measurement-based strategy to reduce bleeding and waiting time in clopidogrel-treated patients undergoing coronary artery bypass graft surgery: the timing based on platelet function strategy to reduce clopidogrel-associated bleeding related to CABG (TARGET-CABG) study, Circ Cardiovasc Interv, 5, 261, 10.1161/CIRCINTERVENTIONS.111.967208 · DOI · Paper page
  130. Angiolillo, 2012, Bridging anti-platelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial, JAMA, 307, 265, 10.1001/jama.2011.2002 · DOI · Paper page
  131. Pengo, 2009, Standardized Low-Molecular-Weight Heparin Bridging Regimen in Outpatients on Oral Anticoagulants Undergoing Invasive Procedure or Surgery An Inception Cohort Management Study, Circulation, 119, 2920, 10.1161/CIRCULATIONAHA.108.823211 · DOI
  132. Huber, 2013, Practical use of dabigatran etexilate for stroke prevention in atrial fibrillation, Int J Clin Pract, 67, 516, 10.1111/ijcp.12147 · DOI
  133. De Caterina, 2012, New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease position paper, J Am Coll Cardiol, 59, 1413, 10.1016/j.jacc.2012.02.008 · DOI · Paper page
  134. Heidbuchel, 2013, European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation, Europace, 15, 625, 10.1093/europace/eut083 · DOI · Paper page
  135. Weitz, 2012, Periprocedural management and approach to bleeding in patients taking dabigatran, Circulation, 126, 2428, 10.1161/CIRCULATIONAHA.112.123224 · DOI
  136. Eerenberg, 2011, Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects, Circulation, 124, 1573, 10.1161/CIRCULATIONAHA.111.029017 · DOI · Paper page
  137. Díaz, 2013, Use of prothrombin complex concentrates for urgent reversal of dabigatran in the Emergency Department, Haematologica, 98, e143, 10.3324/haematol.2013.092767 · doi:10.3324/haematol.2013.092767
  138. Camm, 2012, 2012 focussed update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association, Eur Heart J, 33, 2719
  139. Dawood, 1996, Pathology of fatal peri-operative myocardial infarction: implications regarding pathophysiology and prevention, Int J Cardiol, 57, 37, 10.1016/S0167-5273(96)02769-6 · DOI · Paper page
  140. Devereaux, 2005, Peri-operative cardiac events in patients undergoing noncardiac surgery: a review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk, CMAJ, 173, 627, 10.1503/cmaj.050011 · DOI · Paper page
  141. Eagle, 1997, Cardiac risk of noncardiac surgery: Influence of coronary disease and type of surgery in 3368 operations, Circulation, 96, 1882, 10.1161/01.CIR.96.6.1882 · DOI
  142. Mookadam, 2011, Risk of adverse events after coronary artery bypass graft and subsequent noncardiac surgery, Future Cardiol, 7, 69, 10.2217/fca.10.116 · doi:10.2217/fca.10.116
  143. Assali, 2009, The risk of cardiac complications following noncardiac surgery in patients with drug eluting stents implanted at least six months before surgery, Catheter Cardiovasc Interv, 74, 837
  144. Wijeysundera, 2012, Risk of elective major noncardiac surgery after coronary stent insertion: a population-based study, Circulation, 126, 1355, 10.1161/CIRCULATIONAHA.112.102715 · DOI · Paper page
  145. Brilakis, 2005, Outcome of patients undergoing balloon angioplasty in the two months prior to noncardiac surgery, Am J Cardiol, 96, 512, 10.1016/j.amjcard.2005.04.011 · doi:10.1016/j.amjcard.2005.04.011
  146. McFalls, 2004, Coronary-artery revascularization before elective major vascular surgery, New Engl J Med, 351, 2795, 10.1056/NEJMoa041905 · DOI · Paper page
  147. Monaco, 2009, Systematic strategy of prophylactic coronary angiography improves long-term outcome after major vascular surgery in medium- to high-risk patients: a prospective, randomized study, J Am Coll Cardiol, 54, 989, 10.1016/j.jacc.2009.05.041 · DOI · Paper page
  148. Wong, 2007, The effects of prophylactic coronary revascularization or medical management on patient outcomes after noncardiac surgery: a meta-analysis, Can J Anaesth, 54, 705, 10.1007/BF03026867 · DOI
  149. Mohr, 2013, Coronary artery bypass graft surgery vs. percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial, Lancet, 381, 629, 10.1016/S0140-6736(13)60141-5 · DOI · Paper page
  150. Matteau, 2012, Optimal timing of noncardiac surgery after stents, Circulation, 126, 1322, 10.1161/CIRCULATIONAHA.112.129015 · doi:10.1161/circulationaha.112.129015
  151. Bangalore, 2012, Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials, Circulation, 125, 2873, 10.1161/CIRCULATIONAHA.112.097014 · DOI · Paper page
  152. Livhits, 2011, Coronary revascularization after myocardial infarction can reduce risks of noncardiac surgery, J Am Coll Surg, 212, 1018, 10.1016/j.jamcollsurg.2011.02.018 · doi:10.1016/j.jamcollsurg.2011.02.018
  153. Mosterd, 2007, Clinical epidemiology of heart failure, Heart, 93, 1137, 10.1136/hrt.2003.025270 · DOI · Paper page
  154. Sabaté, 2011, Incidence and predictors of major peri-operative adverse cardiac and cerebrovascular events in non-cardiac surgery, Br J Anaesth, 107, 879, 10.1093/bja/aer268 · DOI · Paper page
  155. Pannell, 2013, Cardiac risk assessment before non-cardiac surgery, Eur Heart J Cardiovasc Imaging, 14, 316, 10.1093/ehjci/jes288 · doi:10.1093/ehjci/jes288
  156. Hammill, 2008, Impact of heart failure on patients undergoing major noncardiac surgery, Anesthesiology, 108, 559, 10.1097/ALN.0b013e31816725ef · DOI · Paper page
  157. Upshaw, 2013, Pre-operative cardiac risk assessment for noncardiac surgery in patients with heart failure, Curr Heart Fail Rep, 10, 147, 10.1007/s11897-013-0136-x · doi:10.1007/s11897-013-0136-x
  158. Kazmers, 1988, Peri-operative and late outcome in patients with left ventricular ejection fraction of 35% or less who require major vascular surgery, J Vasc Surg, 8, 307, 10.1016/0741-5214(88)90283-2 · DOI
  159. Xu-Cai, 2008, Outcomes of patients with stable heart failure undergoing elective noncardiac surgery, Mayo Clin Proc, 83, 280, 10.4065/83.3.280 · DOI
  160. Healy, 2010, Peri-operative outcome and long-term mortality for heart failure patients undergoing intermediate- and high-risk noncardiac surgery: impact of left ventricular ejection fraction, Congest Heart Fail, 16, 45, 10.1111/j.1751-7133.2009.00130.x · DOI
  161. Meta-analysis global group in chronic heart failure (MAGGIC), 2012, The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis, Eur Heart J, 33, 1750, 10.1093/eurheartj/ehr254 · DOI · Paper page
  162. Lang, 2006, Recommendations for chamber quantification, Eur J Echocardiogr, 7, 79, 10.1016/j.euje.2005.12.014 · DOI · Paper page
  163. Mor-Avi, 2011, Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography, Eur J Echocardiogr, 12, 167, 10.1093/ejechocard/jer021 · DOI · Paper page
  164. Cowie, 2012, Focussed transthoracic echocardiography predicts peri-operative cardiovascular morbidity, J Cardiothorac Vasc Anesth, 26, 989, 10.1053/j.jvca.2012.06.031 · doi:10.1053/j.jvca.2012.06.031
  165. Wijeysundera, 2011, Association of echocardiography before major elective non-cardiac surgery with post-operative survival and length of hospital stay: population based cohort study, BMJ, 342, 10.1136/bmj.d3695 · DOI
  166. Canty, 2012, The impact on cardiac diagnosis and mortality of focussed transthoracic echocardiography in hip fracture surgery patients with increased risk of cardiac disease: a retrospective cohort study, Anaesthesia, 67, 1202, 10.1111/j.1365-2044.2012.07300.x · doi:10.1111/j.1365-2044.2012.07300.x
  167. Raman, 2009, The CMR examination in heart failure, Heart Fail Clin, 5, 283, 10.1016/j.hfc.2009.02.002 · DOI
  168. Biccard, 2012, The influence of clinical risk factors on pre-operative B-type natriuretic peptide risk stratification of vascular surgical patients, Anaesthesia, 67, 55, 10.1111/j.1365-2044.2011.06958.x · DOI
  169. Rajagopalan, 2011, N-terminal pro-B-type natriuretic peptide is an independent predictor of all-cause mortality and MACE after major vascular surgery in medium-term follow-up, Eur J Vasc Endovasc Surg, 41, 657, 10.1016/j.ejvs.2010.12.017 · doi:10.1016/j.ejvs.2010.12.017
  170. Guazzi, 2012, EACPR/AHA Joint Scientific Statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations, Eur Heart J, 33, 2917, 10.1093/eurheartj/ehs221 · DOI · Paper page
  171. Young, 2012, A systematic review of the role of cardiopulmonary exercise testing in vascular surgery, Eur J Vasc Endovasc Surg, 44, 64, 10.1016/j.ejvs.2012.03.022 · DOI
  172. Smith, 2009, Cardiopulmonary exercise testing as a risk assessment method in non cardio-pulmonary surgery: a systematic review, Anaesthesia, 64, 883, 10.1111/j.1365-2044.2009.05983.x · DOI · Paper page
  173. Rosenman, 2008, Clinical consequences of withholding vs. administering renin-angiotensin-aldosterone system antagonists in the pre-operative period, J Hosp Med, 3, 319, 10.1002/jhm.323 · DOI
  174. Howell, 2004, Hypertension, hypertensive heart disease and peri-operative cardiac risk, Br J Anaesth, 92, 570, 10.1093/bja/aeh091 · DOI · Paper page
  175. Casadei, 2005, Is there a strong rationale for deferring elective surgery in patients with poorly controlled hypertension?, J Hypertens, 23, 19, 10.1097/00004872-200501000-00005 · DOI
  176. Mancia, 2013, 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC), Eur Heart J, 34, 2159, 10.1093/eurheartj/eht151 · DOI · Paper page
  177. Kihara, 2003, Hemodynamic responses among three tracheal intubation devices in normotensive and hypertensive patients, Anesth Analg, 96
  178. Charlson, 1990, Intra-operative blood pressure. What patterns identify patients at risk for post-operative complications?, Ann Surg, 212, 567, 10.1097/00000658-199011000-00003 · doi:10.1097/00000658-199011000-00003
  179. Weksler, 2003, The dilemma of immediate pre-operative hypertension: To treat and operate, or to postpone surgery?, Journal of Clinical Anesthesia, 15, 179, 10.1016/S0952-8180(03)00035-7 · doi:10.1016/s0952-8180(03)00035-7
  180. Goldman, 1979, Risks of general anesthesia and elective operation in the hypertensive patient, Anesthesiology, 50, 285, 10.1097/00000542-197904000-00002 · DOI · Paper page
  181. Calleja, 2010, Cardiac risk in patients aged >75 years with asymptomatic, severe aortic stenosis undergoing noncardiac surgery, Am J Cardiol, 105, 1159, 10.1016/j.amjcard.2009.12.019 · DOI
  182. Fleisher, 2007, ACC/AHA 2007 guidelines on peri-operative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Peri-operative Cardiovascular Evaluation for Noncardiac Surgery) developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery, J Am Coll Cardiol, 50
  183. Habib, 2009, Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer, Eur Heart J, 30, 2369, 10.1093/eurheartj/ehp285 · DOI · Paper page
  184. Zipes, 2006, ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society, Eur Heart J, 27, 2099, 10.1093/eurheartj/ehl199 · DOI · Paper page
  185. Balser, 1998, beta-adrenergic blockade accelerates conversion of post-operative supraventricular tachyarrhythmias, Anesthesiology, 89, 1052, 10.1097/00000542-199811000-00004 · DOI
  186. Healey, 2012, Canadian Cardiovascular Society/Canadian Anesthesiologists' Society/Canadian Heart Rhythm Society joint position statement on the peri-operative management of patients with implanted pacemakers, defibrillators, and neurostimulating devices, Can J Cardiol, 28, 141
  187. Bihorac, 2009, Long-term risk of mortality and acute kidney injury during hospitalization after major surgery, Ann Surg, 249, 851, 10.1097/SLA.0b013e3181a40a0b · DOI · Paper page
  188. Kheterpal, 2009, Development and validation of an acute kidney injury risk index for patients undergoing general surgery: results from a national data set, Anesthesiology, 110, 505, 10.1097/ALN.0b013e3181979440 · DOI · Paper page
  189. Earley, 2012, Estimating equations for glomerular filtration rate in the era of creatinine standardization: a systematic review, Ann Intern Med, 156, 785, 10.7326/0003-4819-156-11-201203200-00391 · DOI · Paper page
  190. McCullough, 2005, Contrast-induced nephropathy, Crit Care Clin, 21, 261, 10.1016/j.ccc.2004.12.003 · DOI · Paper page
  191. Cruz, 2012, Renal replacement therapies for prevention of radiocontrast-induced nephropathy: a systematic review, Am J Med, 125, 66, 10.1016/j.amjmed.2011.06.029 · DOI
  192. Jang, 2012, Sodium bicarbonate therapy for the prevention of contrast-induced acute kidney injury—a systematic review and meta-analysis, Circ J, 76, 2255, 10.1253/circj.CJ-12-0096 · doi:10.1253/circj.cj-12-0096
  193. Leoncini, 2013, Early high-dose rosuvastatin for Contrast-Induced Nephropathy Prevention in Acute Coronary Syndrome. Results from Protective effect of Rosuvastatin and Anti-platelet Therapy On contrast-induced acute kidney injury and myocardial damage in patients with Acute Coronary Syndrome (PRATO-ACS Study), J Am Coll Cardiol
  194. Selim, 2007, Peri-operative stroke, N Engl J Med, 356, 706, 10.1056/NEJMra062668 · DOI · Paper page
  195. Macellari, 2012, Peri-operative stroke risk in nonvascular surgery, Cerebrovasc Dis, 34, 175, 10.1159/000339982 · doi:10.1159/000339982
  196. Mashour, 2011, Peri-operative stroke and associated mortality after noncardiac, nonneurologic surgery, Anesthesiology, 114, 1289, 10.1097/ALN.0b013e318216e7f4 · DOI · Paper page
  197. Ng, 2011, Peri-operative stroke in noncardiac, nonneurosurgical surgery, Anesthesiology, 115, 879, 10.1097/ALN.0b013e31822e9499 · DOI
  198. Ahmed, 2009, Prevalence of significant asymptomatic carotid artery disease in patients with peripheral vascular disease: a meta-analysis, Eur J Vasc Endovasc Surg, 37, 262, 10.1016/j.ejvs.2008.10.017 · DOI
  199. Hofmann, 2005, Coronary angiography in patients undergoing carotid artery stenting shows a high incidence of significant coronary artery disease, Heart, 91, 1438, 10.1136/hrt.2004.050906 · DOI
  200. Tendera, 2011, ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC), Eur Heart J, 32, 2851, 10.1093/eurheartj/ehr211 · DOI · Paper page

200 of 264 shown

Cited by

See all 1,656

Metadata

Venue
European Heart Journal
Published
2014-08-01
Volume
35
Issue
35
Pages
2383-2431
ISSN
  • 0195-668X (ISSN-L)
  • 1522-9645
OpenAlex
W2285459543
Cited by
1,656
References
12
FWCI
90.55
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). https://app.cochat.ai/papers/10.1093/eurheartj/ehu282
The paper
2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). (2014). European Heart Journal. https://doi.org/10.1093/eurheartj/ehu282

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.